?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
496 Unternehmen gefunden • Seite 8 von 20
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yuhan Corp. | 50.7 | Arzneimittel (Pharmazeutisch) | Südkorea | 4.2 Mrd. USD | 23.56 | - | 2.45 | 2.34 | ▲ 6.18% | ▲ 0.14% | 0.78% | - | - | 8.88% | ▲ 0.37% | 4.77% | ▲ 0.44% | -1.76% | ▼ -1.55% | 7 / 9 | 7,19 | 13-fach | 23 / 100 | 2,8 / 100 | −2,26 | |
| Hualan Biological Bacterin Inc. | 50.6 | Arzneimittel (Biotechnologie) | China | 1.3 Mrd. USD | 183.85 | - | 12.17 | 1.64 | ▼ -13.10% | ▼ -27.68% | 9.25% | - | 3 Jahre | 15.21% | ▼ -4.77% | 15.60% | ▼ -5.95% | 28.89% | ▲ 9.13% | 8 / 9 | 9,52 | > 50-fach | 14 / 100 | −2,6 / 100 | −3,53 | |
![]() | ANI Pharmaceuticals Inc | 50.6 | Arzneimittel (Pharmazeutisch) | USA | 1.6 Mrd. USD | 15.57 | 12.04 | 1.68 | 2.76 | ▲ 33.48% | - | - | - | - | 8.87% | ▲ 6.93% | 9.20% | ▲ 6.65% | 17.08% | ▲ 7.57% | 6 / 9 | 3,28 | 2-fach | 31 / 100 | −7,4 / 100 | −2,62 |
| Beijing Tongrentang Co Ltd | 50.6 | Arzneimittel (Pharmazeutisch) | China | 5.0 Mrd. USD | 34.54 | - | 2.11 | 2.46 | ▲ 6.11% | ▲ 2.89% | 2.02% | ▲ 5.06% | 2 Jahre | 6.89% | ▼ -0.41% | 12.10% | ▼ -1.03% | 13.53% | ▼ -3.01% | 6 / 9 | 8,27 | 21-fach | 32 / 100 | −6,6 / 100 | −3,80 | |
| Ono Pharmaceutical Co Ltd | 50.5 | Arzneimittel (Pharmazeutisch) | Japan | 7.3 Mrd. USD | 14.85 | 8.72 | 2.25 | 1.34 | ▲ 12.07% | ▼ -0.39% | 3.25% | ▼ -63.55% | - | 13.53% | ▼ -3.24% | 20.03% | ▼ -3.65% | 25.36% | ▲ 0.61% | 7 / 9 | 8,47 | 36-fach | 36 / 100 | −6,4 / 100 | −2,81 | |
![]() | Ipsen SA | 50.4 | Arzneimittel (Pharmazeutisch) | Frankreich | 14.4 Mrd. USD | 15.17 | 10.47 | 3.17 | 2.73 | ▲ 6.47% | ▼ -4.10% | 1.05% | ▲ 9.86% | 1 Jahre | 12.09% | ▼ -3.37% | 20.30% | ▼ -3.99% | 28.10% | ▲ 0.21% | 8 / 9 | 3,90 | 10-fach | 37 / 100 | −10,0 / 100 | −2,57 |
| Zhejiang Medicine Co Ltd | 50.3 | Arzneimittel (Pharmazeutisch) | China | 1.5 Mrd. USD | 16.12 | - | 1.21 | 0.91 | ▲ 3.92% | ▲ 4.01% | 2.57% | ▲ 16.27% | - | 9.83% | ▲ 0.25% | 12.15% | ▲ 0.53% | 16.21% | ▲ 3.94% | 6 / 9 | 8,03 | 30-fach | 22 / 100 | −7,3 / 100 | −3,19 | |
![]() | Lineage Cell Therapeutics Inc | 50.0 | Arzneimittel (Biotechnologie) | USA | 0.3 Mrd. USD | - | - | 20.10 | 4.32 | ▲ 79.88% | ▲ 25.20% | - | - | - | -436.47% | ▲ 131.82% | -149.62% | ▲ 215.40% | -133.56% | ▲ 70.71% | 4 / 9 | −14,00 | - | 12 / 100 | −39,2 / 100 | −3,22 |
![]() | Fennec Pharmaceuticals Inc | 50.0 | Arzneimittel (Biotechnologie) | USA | 0.4 Mrd. USD | - | - | 6.44 | 8.98 | ▲ 204.69% | ▼ -11.66% | - | - | - | -21.82% | ▲ 2190.74% | -14.22% | ▲ 2172.04% | -27.94% | ▲ 1790.91% | 1 / 9 | −5,10 | −1,7-fach | 58 / 100 | 3,9 / 100 | −0,84 |
| High Tide Inc | 49.8 | Arzneimittel (Pharmazeutisch) | Kanada | 0.2 Mrd. USD | - | 21.02 | 0.46 | 3.18 | ▲ 48.14% | ▲ 51.52% | - | - | - | -8.54% | ▲ 4.01% | -2.43% | ▲ 3.70% | 2.23% | ▲ 2.56% | 3 / 9 | −2,21 | −1,8-fach | 46 / 100 | −22,4 / 100 | −3,41 | |
| Galderma Group N | 49.3 | Arzneimittel (Pharmazeutisch) | Schweiz | 52.6 Mrd. USD | 61.45 | 50.94 | 9.00 | 6.39 | - | - | 0.19% | - | - | 12.25% | ▲ 4.13% | 15.82% | ▲ 1.78% | 19.67% | ▲ 3.98% | 7 / 9 | 3,77 | 2-fach | 27 / 100 | −4,1 / 100 | −2,58 | |
![]() | Liquidia Technologies Inc | 49.2 | Arzneimittel (Pharmazeutisch) | USA | 4.0 Mrd. USD | 29.05 | 66.55 | 8.93 | 20.64 | ▲ 192.49% | ▲ 2.89% | - | - | - | -43.53% | ▼ -22.33% | -32.45% | ▼ -16.23% | -25.28% | ▼ -3.90% | 5 / 9 | −5,88 | −5,5-fach | 44 / 100 | −10,1 / 100 | 6,03 |
| Guobang Pharma Ltd | 49.0 | Arzneimittel (Pharmazeutisch) | China | 1.7 Mrd. USD | 18.24 | - | 1.85 | 1.33 | ▲ 7.40% | ▲ 0.27% | 2.89% | - | - | 13.65% | ▼ -0.69% | 16.00% | ▼ -0.71% | 4.68% | ▲ 3.82% | 6 / 9 | 8,02 | 31-fach | 14 / 100 | 2,4 / 100 | −2,56 | |
![]() | Madrigal Pharmaceuticals Inc | 48.8 | Arzneimittel (Biotechnologie) | USA | 10.0 Mrd. USD | - | - | 7.76 | 19.01 | ▲ 130.27% | ▲ 50.40% | - | - | - | -30.08% | ▲ 4364.50% | -31.31% | ▲ 4241.55% | -19.83% | ▲ 3814.23% | 3 / 9 | −0,99 | −19,9-fach | 72 / 100 | −7,8 / 100 | 0,59 |
| Nanjing King-friend Biochemical Pharmaceutical Co Ltd | 48.5 | Arzneimittel (Pharmazeutisch) | China | 2.0 Mrd. USD | 27.07 | 86.22 | 3.32 | 1.88 | ▲ 6.48% | ▼ -6.32% | 1.24% | - | - | 14.57% | ▼ -3.66% | 14.57% | ▼ -4.12% | 15.60% | ▲ 4.00% | 6 / 9 | 6,61 | 8-fach | 15 / 100 | −5,8 / 100 | −2,95 | |
![]() | Phibro Animal Health Corporation | 48.4 | Arzneimittel (Pharmazeutisch) | USA | 1.5 Mrd. USD | 15.42 | 155.89 | 1.01 | 3.99 | ▲ 12.74% | ▲ 12.89% | 1.23% | - | - | 6.57% | ▲ 0.31% | 13.07% | ▲ 1.06% | 0.65% | ▲ 0.96% | 6 / 9 | 4,66 | 3-fach | 34 / 100 | 2,1 / 100 | −2,31 |
![]() | Novavax Inc | 48.4 | Arzneimittel (Biotechnologie) | USA | 1.7 Mrd. USD | - | - | 4.11 | -8.93 | ▲ 18.76% | - | - | - | - | 39.19% | ▲ 39.63% | 50.14% | ▲ 39.84% | -22.27% | ▼ -7.37% | 6 / 9 | −7,22 | −3,8-fach | 89 / 100 | 58,2 / 100 | 0,66 |
| Zhejiang Garden Bio-chemical High-tech Co Ltd | 48.3 | Arzneimittel (Pharmazeutisch) | China | 1.0 Mrd. USD | 27.50 | - | 5.16 | 1.82 | ▲ 13.41% | ▲ 2.98% | 0.92% | ▲ 1.87% | - | 24.64% | ▼ -3.95% | 30.95% | ▼ -4.53% | 9.11% | ▲ 5.37% | 6 / 9 | 5,11 | 10-fach | 12 / 100 | −2,9 / 100 | −2,17 | |
| PKU HealthCare Corp Ltd | 48.3 | Arzneimittel (Pharmazeutisch) | China | 0.5 Mrd. USD | 151.32 | - | 3.47 | 2.06 | ▼ -5.60% | ▲ 16.17% | 3.02% | - | - | 5.59% | ▲ 1.13% | 10.68% | ▲ 2.07% | 22.84% | ▲ 4.77% | 7 / 9 | 9,52 | 26-fach | 21 / 100 | −15,3 / 100 | −3,71 | |
| RemeGen Co. Ltd. A | 48.2 | Arzneimittel (Biotechnologie) | China | 7.9 Mrd. USD | 74.55 | - | 16.25 | 22.77 | - | - | - | - | - | 21.79% | ▲ 4.86% | 22.19% | ▲ 6.56% | -4.42% | ▲ 21.87% | 5 / 9 | −3,55 | −12,7-fach | 25 / 100 | −5,3 / 100 | −2,84 | |
![]() | Hangzhou Tigermed Consulting Co Ltd | 48.2 | Arzneimittel (Biotechnologie) | China | 4.2 Mrd. USD | 296.19 | 22.99 | 3.80 | 1.42 | ▲ 16.44% | ▼ -12.69% | 0.37% | ▼ -16.75% | - | 12.99% | ▼ -10.65% | 14.77% | ▼ -7.05% | 13.23% | ▼ -1.56% | 7 / 9 | 7,74 | 13-fach | 7 / 100 | −0,9 / 100 | −2,32 |
![]() | Harrow Health Inc | 48.0 | Arzneimittel (Pharmazeutisch) | USA | 1.1 Mrd. USD | - | 207.96 | 4.00 | 72.48 | ▲ 40.99% | ▲ 8.89% | - | - | - | -1.89% | ▲ 5.31% | 14.18% | ▲ 2.62% | 15.70% | ▲ 7.24% | 6 / 9 | 1,15 | 0-fach | 51 / 100 | −12,3 / 100 | −3,04 |
![]() | Hikma Pharmaceuticals PLC | 47.9 | Arzneimittel (Pharmazeutisch) | Vereinigtes Königreich - UK | 4.8 Mrd. USD | 12.34 | 32.16 | 1.40 | 1.88 | ▲ 7.42% | ▼ -1.38% | 3.78% | ▲ 17.48% | - | 12.00% | ▼ -0.50% | 17.32% | ▼ -1.89% | 4.94% | ▼ -2.15% | 6 / 9 | 4,49 | 6-fach | 25 / 100 | 0,6 / 100 | −2,17 |
| Walvax BioTech | 47.7 | Arzneimittel (Biotechnologie) | China | 2.8 Mrd. USD | 97.52 | - | 8.77 | 2.64 | ▼ -3.89% | ▼ -29.26% | 1.27% | ▲ 20.11% | - | 7.37% | ▼ -1.92% | 2.90% | ▼ -5.34% | -0.63% | ▲ 3.68% | 6 / 9 | 6,55 | > 50-fach | 15 / 100 | −2,9 / 100 | −2,72 | |
| YungShin Global Holding Corp | 47.6 | Arzneimittel (Pharmazeutisch) | Taiwan | 0.5 Mrd. USD | 17.77 | 17.84 | 2.03 | 2.04 | ▲ 0.71% | ▲ 2.16% | 5.07% | - | 1 Jahre | 10.52% | ▲ 0.52% | 15.71% | ▲ 1.25% | 12.00% | ▲ 0.70% | 5 / 9 | 6,44 | > 50-fach | 31 / 100 | −5,4 / 100 | −3,87 |